MétaCan
Menu
← Retour à la cohorte
Enregistrement W1998023512 · doi:10.1177/1715163514522764

Increasing the safe and effective use of medications

2014· article· en· W1998023512 sur OpenAlexaffvenueabout
Jeff Morrison

Notice bibliographique

RevueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada · 2014
Typearticle
Langueen
DomaineMedicine
ThématiquePharmaceutical Practices and Patient Outcomes
Établissements canadiensCanadian Pharmacists Association
Organismes subventionnairesnon disponible
Mots-clésMedicineIntensive care medicine

Résumé

récupéré en direct d'OpenAlex

One of the most underreported health-related stories of 2013 was the increased emphasis that the federal government has placed on the issue of prescription drug abuse and drug safety. Ottawa was clear in the Speech from the Throne in October 2013 that it would undertake a series of measures to increase patient safety and reduce medication-related errors, an important promise when one considers that up to 1 in 9 hospitalizations result from adverse drug reactions (ADRs). The government is thus far living up to that commitment. Over the past year, we have seen the introduction of a variety of measures designed to strengthen drug safety and reduce prescription drug abuse, notably the following: In June, the federal government announced its plain language labeling initiative, to ensure that drug labels and safety information are available in plain language so Canadians can better understand how and when to take their medications. As part of this initiative, Health Canada is providing $3.2 million to the Institute for Safe Medication Practices Canada to study the reasons behind medication misuse. In December, the Minister of Health tabled in the House of Commons Bill C-17, the Protecting Canadians from Unsafe Drugs Act, otherwise known as “Vanessa’s Law” (named in honour of Vanessa Young, the daughter of Conservative Member of Parliament Terence Young, who died after taking a prescription drug that was later found to be unsafe and was withdrawn from the market). Among other things, this bill will provide the federal government with powers to recall medications proven to be unsafe, will require mandatory ADR reporting by hospitals (the definition of a reportable reaction will be decided as regulations are developed) and will compel drug companies to revise labels to clearly reflect health risk information, including updates for health warnings for children. Also in December, several Conservative Members of Parliament held consultations with stakeholders to develop a strategy on a national Take Back Your Medications day, which would be a national initiative aimed at encouraging Canadians to drop off any unused medications to designated locations, possibly including pharmacies. Although a federally run Take Back Your Medications day remains a longer-term objective, the Minister of Health has been open to the idea. Over the fall, the House of Commons Standing Committee on Health held hearings into the government’s role in addressing prescription drug abuse. The Committee has already heard from many witnesses, including CPhA, on how the government can continue to play a role in improving the safe and effective use of medications. A report from the Committee is expected in spring 2014, with possible additional actions after that. The Canadian Pharmacists Association (CPhA) has been at the forefront in supporting and encouraging these initiatives. CPhA provided input into the development of these initiatives, expressed its qualified support for measures addressing drug safety and continues to meet with Health Canada officials to provide feedback into policy in this area. During its appearance before the Standing Committee on Health, CPhA argued for such measures as expanding scope of practice so that pharmacists could address safety issues head-on, enhancing training opportunities for pharmacists and ensuring that regulations prevent the entry of drugs with high risks of addiction to market. There is no question that drug safety and appropriate use of medication are the top priority of pharmacists. Recent media stories have called into question the safety and efficacy of medications in Canada. By supporting these measures and continuing to have a dialogue with the federal government on additional ways in which medication safety can be improved, CPhA, on behalf of pharmacists across Canada, is making it clear that safety is priority number one for the profession. ■

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,014
score de la tête « metaresearch » (Gemma)0,078
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: aucune
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,055
Score d'incertitude au seuil0,118

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0140,078
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0020,001
Études des sciences et des technologies0,0020,003
Communication savante0,0050,006
Science ouverte0,0020,006
Intégrité de la recherche0,0030,007
Charge utile insuffisante (le modèle a refusé de juger)0,0350,011

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,079
Tête enseignante GPT0,333
Écart entre enseignants0,255 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2014
Routes d'admission3
Résumé présentoui

Explorer davantage

Même revueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada→Même sujetPharmaceutical Practices and Patient Outcomes→Travaux en français237 207→